Publications by authors named "Philip P Halloran"
Front Med (Lausanne)
July 2021
Article Synopsis
- - Mesenchymal stem cells (MSCs) are being researched for their potential benefits in kidney transplantation due to their ability to help the immune system and promote healing.
- - Clinical trials have shown that MSCs are generally safe and well-tolerated when used around the time of kidney transplant, but there's limited information about their effects later on.
- - This case report describes a serious complication resembling capillary leak syndrome that led to kidney transplant failure after using MSCs as a last-ditch effort to treat late-stage rejection of a transplanted kidney.
